Autumn Dawn Lang

Autumn Dawn Lang, PhD, RAC

Co-Founder & CEO

confinis CPM AG

Accomplished strategic clinical affairs leader with effective negotiation and communication skills. Demonstrated compliance of over 20 years in diverse clinical affair roles in the medical device and clinical research industry. Understands what stakeholders’ value most in outsourcing their clinical research: accomplished team (been there, learned that), reliable team (low or no turnover during project) and affordable (no passive overhead costs).

Specialty is chartering the clinical research pathway to market access and commercialization for medical device companies. Innovating from a proven concept by being able to answer questions about what kind of clinical data is needed, where is the best environment to obtain this clinical data and ensuring economic clinical data is gathered to bridge the time to reimbursement and/or tipping point of commercialization.

Clinical research business know-how on driving new streams of revenue and understanding why growth is critical for the clinical research industry in the medical device sector. Medical devices have no geographical development boundaries.

Other speakers in 2020

Dr. Nadia Cheaib

France

Dr. Nadia Cheaib

Global Health Social & Philanthropist Entrepreneur / Chairwoman, President and CEO of Clingroup / President Hope MCF / President Health Commission, French Chamber Egypt / Ambassador at Egypt International Health Congress
Dr. Evgeni Evgeniev

Bulgaria

Dr. Evgeni Evgeniev

Research Attaché
Permanent Representation of Bulgaria to the European Union
Prof. Daniel Mueller

Canada

Prof. Daniel Mueller, MD, PhD

Head, Pharmacogenetics Research Clinic and Staff Psychiatrist, Genaral Adult Psychiatry, Centre for Addiction and Mental Health (CAMH), Toronto
Professor at Department of Psychiatry and Department of Pharmacology & Toxicology , University of Toronto
Skip to content